American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts
Source: Food and Drugs Administration--Recalls/Safety Alerts